首页> 外文OA文献 >Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

【2h】

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

机译：勘误：一项针对患有1型Charcot-Marie-Tooth病的患者使用巴氯芬，纳曲酮和山梨糖醇（PXT3003）进行的探索性随机双盲和安慰剂对照2期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Shahram Attarian; Jean-Michel Vallat; Laurent Magy; Benoît Funalot; Pierre-Marie Gonnaud; Arnaud Lacour; Yann Péréon; Odile Dubourg; Jean Pouget; Joëlle Micallef; Jérôme Franques; Marie-Noëlle Lefebvre; Karima Ghorab; Mahmoud Al-Moussawi; Vincent Tiffreau; Marguerite Preudhomme; Armelle Magot; Laurène Leclair-Visonneau; Tanya Stojkovic; Laura Bossi; Philippe Lehert; Walter Gilbert; Viviane Bertrand; Jonas Mandel; Aude Milet; Rodolphe Hajj; Lamia Boudiaf; Catherine Scart-Grès; Serguei Nabirotchkin; Mickael Guedj; Ilya Chumakov; Daniel Cohen;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A [J] . Shahram Attarian, Jean-Michel Vallat, Laurent Magy, Orphanet journal of rare diseases . 2014,第S1期

机译：一项探索性随机双盲和安慰剂对照2期研究，对氯丁酸，纳曲酮和山梨糖醇（PXT3003）联合治疗1A型Charcot-Marie-Tooth病患者
2. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A [J] . Shahram Attarian, Jean-Michel Vallat, Laurent Magy, Orphanet journal of rare diseases . 2014,第46期

机译：一项探索性随机双盲和安慰剂对照2期研究，对氯丁酸，纳曲酮和山梨糖醇（PXT3003）联合治疗1A型Charcot-Marie-Tooth病患者
3. Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study [J] . Weber Michael A., Mansfield Traci A., Cain Valerie A., The lancet. Diabetes & endocrinology. . 2016,第3期

机译：达格列净与安慰剂对2型糖尿病患者联合降压治疗的血压和血糖影响：一项随机，双盲，安慰剂对照的3期研究
4. Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A [O] . Shahram Attarian, Jean-Michel Vallat, Laurent Magy, 2016

机译：勘误：一项针对患有1型Charcot-Marie-Tooth病的患者使用巴氯芬纳曲酮和山梨糖醇（PXT3003）进行的探索性随机双盲和安慰剂对照2期研究
5. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A [O] . 2014

机译：一项探索性随机双盲和安慰剂对照的2期研究，对氯丁酸，纳曲酮和山梨糖醇（PXT3003）联合治疗1A型Charcot-Marie-Tooth病患者

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

著录项

相似文献

相关主题

期刊订阅